• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型芳基氟喹诺酮类抗菌剂的合成及其构效关系

Synthesis and structure-activity relationships of novel arylfluoroquinolone antibacterial agents.

作者信息

Chu D T, Fernandes P B, Claiborne A K, Pihuleac E, Nordeen C W, Maleczka R E, Pernet A G

出版信息

J Med Chem. 1985 Nov;28(11):1558-64. doi: 10.1021/jm00149a003.

DOI:10.1021/jm00149a003
PMID:3934382
Abstract

A series of novel arylfluoroquinolones has been prepared. These derivatives are characterized by having a fluorine atom at the 6-position, substituted amino groups at the 7-position, and substituted phenyl groups at the 1-position. Structure-activity relationship (SAR) studies indicate that the in vitro antibacterial potency is greatest when the 1-substituent is either p-fluorophenyl or p-hydroxyphenyl and the 7-substituent is either 1-piperazinyl, 4-methyl-1-piperazinyl, or 3-amino-1-pyrrolidinyl. The electronic and spatial properties of the 1-substituent, as well as the steric bulk, play important roles in the antimicrobial potency in this class of antibacterials. As a result of this study, compounds 45 and 41 were found to possess excellent in vitro potency and in vivo efficacy.

摘要

已经制备了一系列新型芳基氟喹诺酮类化合物。这些衍生物的特征在于在6位具有氟原子,在7位具有取代的氨基,在1位具有取代的苯基。构效关系(SAR)研究表明,当1-取代基为对氟苯基或对羟基苯基且7-取代基为1-哌嗪基、4-甲基-1-哌嗪基或3-氨基-1-吡咯烷基时,体外抗菌效力最大。1-取代基的电子和空间性质以及空间体积在这类抗菌剂的抗菌效力中起重要作用。作为该研究的结果,发现化合物45和41具有优异的体外效力和体内疗效。

相似文献

1
Synthesis and structure-activity relationships of novel arylfluoroquinolone antibacterial agents.新型芳基氟喹诺酮类抗菌剂的合成及其构效关系
J Med Chem. 1985 Nov;28(11):1558-64. doi: 10.1021/jm00149a003.
2
Synthesis of novel 5-fluoro analogues of norfloxacin and ciprofloxacin.
J Med Chem. 1989 Jun;32(6):1313-8. doi: 10.1021/jm00126a028.
3
Synthesis and biological activity of benzothiazolo[3,2-a]quinolone antibacterial agents.苯并噻唑并[3,2 - a]喹诺酮类抗菌剂的合成及生物活性
J Med Chem. 1986 Aug;29(8):1531-4. doi: 10.1021/jm00158a037.
4
Synthesis and structure-activity relationship of 1-aryl-6,8-difluoroquinolone antibacterial agents.
J Med Chem. 1987 Mar;30(3):504-9. doi: 10.1021/jm00386a011.
5
Novel amino-substituted 3-quinolinecarboxylic acid antibacterial agents: synthesis and structure-activity relationships.新型氨基取代的3-喹啉羧酸类抗菌剂:合成与构效关系
J Med Chem. 1984 Sep;27(9):1103-8. doi: 10.1021/jm00375a003.
6
Synthesis and structure-activity relationships of new 7-[3-(fluoromethyl)piperazinyl]- and -(fluorohomopiperazinyl)quinolone antibacterials.
J Med Chem. 1990 Jan;33(1):142-6. doi: 10.1021/jm00163a024.
7
Activity of E-3846, a new fluoroquinolone, in vitro and in experimental cystitis and pyelonephritis in rats.新型氟喹诺酮类药物E-3846在体外以及大鼠实验性膀胱炎和肾盂肾炎中的活性
Antimicrob Agents Chemother. 1988 May;32(5):636-41. doi: 10.1128/AAC.32.5.636.
8
Synthesis and antibacterial activity of 6-difluoromethoxy-7-piperazinyl-3-quinolinecarboxylic acid derivatives.
J Pharm Sci. 1988 May;77(5):458-60. doi: 10.1002/jps.2600770521.
9
Amifloxacin activity against well-defined gentamicin-resistant, gram-negative bacteria.阿米氟沙星对明确的耐庆大霉素革兰氏阴性菌的活性。
Antimicrob Agents Chemother. 1984 Nov;26(5):781-4. doi: 10.1128/AAC.26.5.781.
10
In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.A-56619(二氟沙星)和A-56620的体内评估:新型芳基氟喹诺酮类药物
Antimicrob Agents Chemother. 1986 Feb;29(2):201-8. doi: 10.1128/AAC.29.2.201.

引用本文的文献

1
Three-Component One-Pot Approach to Highly Efficient and Sustainable Synthesis of the Functionalized Quinolones via Linear/Branched Domino Protocols, Key Synthetic Methods for the Floxacin of Quinolone Drugs.通过线性/支链多米诺反应高效可持续合成功能化喹诺酮的三组分一锅法,喹诺酮类药物氟罗沙星的关键合成方法。
ACS Omega. 2018 Sep 14;3(9):11233-11251. doi: 10.1021/acsomega.8b01378. eCollection 2018 Sep 30.
2
Identification of the Beer Component Hordenine as Food-Derived Dopamine D2 Receptor Agonist by Virtual Screening a 3D Compound Database.通过虚拟筛选三维化合物数据库鉴定啤酒成分霍多宁为食物来源的多巴胺 D2 受体激动剂。
Sci Rep. 2017 Mar 10;7:44201. doi: 10.1038/srep44201.
3
Synthesis of chromone, quinolone, and benzoxazinone sulfonamide nucleosides as conformationally constrained inhibitors of adenylating enzymes required for siderophore biosynthesis.
合成色酮、喹诺酮和苯并恶嗪酮磺酰胺核苷作为构象受限的抑制剂,用于抑制铁载体生物合成所需的腺苷酸酶。
J Org Chem. 2013 Aug 2;78(15):7470-81. doi: 10.1021/jo400976f. Epub 2013 Jul 12.
4
Hybrid antibacterials. DNA polymerase-topoisomerase inhibitors.混合抗菌剂。DNA聚合酶-拓扑异构酶抑制剂。
J Med Chem. 2006 Feb 23;49(4):1455-65. doi: 10.1021/jm0510023.
5
Antibacterial activity and pharmacokinetics of four new 7-azetidinyl fluoroquinolones.四种新型7-氮杂环丁烷基氟喹诺酮类药物的抗菌活性和药代动力学
Antimicrob Agents Chemother. 1996 Jan;40(1):274-7. doi: 10.1128/AAC.40.1.274.
6
Lomefloxacin clinical pharmacokinetics.洛美沙星的临床药代动力学。
Clin Pharmacokinet. 1993 Jul;25(1):6-19. doi: 10.2165/00003088-199325010-00002.
7
E-4695, a new C-7 azetidinyl fluoronaphthyridine with enhanced activity against gram-positive and anaerobic pathogens.E-4695,一种新型的C-7氮杂环丁烷基氟萘啶,对革兰氏阳性菌和厌氧菌具有增强的活性。
Antimicrob Agents Chemother. 1995 Feb;39(2):413-21. doi: 10.1128/AAC.39.2.413.
8
Computer automated structure evaluation of quinolone antibacterial agents.喹诺酮类抗菌剂的计算机自动结构评估
Antimicrob Agents Chemother. 1987 Nov;31(11):1831-40. doi: 10.1128/AAC.31.11.1831.
9
Structure-activity relationships of the fluoroquinolones.氟喹诺酮类药物的构效关系。
Antimicrob Agents Chemother. 1989 Feb;33(2):131-5. doi: 10.1128/AAC.33.2.131.
10
Clinical pharmacokinetics of ciprofloxacin.
Clin Pharmacokinet. 1990 Dec;19(6):434-61. doi: 10.2165/00003088-199019060-00003.